Long-Term Safety and Disease Control With Ruxolitinib Cream in Patients With More Severe Atopic Dermatitis: Pooled Results From Two Phase 3 Studies. J of Skin [Internet]. 2021 Nov. 5 [cited 2026 Jan. 20];5(6):s66. Available from: https://skin.dermsquared.com/skin/article/view/1417